HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphoma

被引：0
|
作者：
Kitadate, Akihiro [1 ]
Ikeda, Sho [1 ]
Abe, Fumito [1 ]
Teshima, Kazuaki [1 ]
Takahashi, Naoto [1 ]
Matsue, Kosei [2 ]
Tagawa, Hiroyuki [1 ]
机构：
[1] Akita Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan
[2] Div Hematol, Akita 010, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Malignant lymphoma; HDAC inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2025
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [21] Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
    Tobinai, Kensei
    Takahashi, Takeshi
    Akinaga, Shiro
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (03) : 235 - 240
  • [22] Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
    Kensei Tobinai
    Takeshi Takahashi
    Shiro Akinaga
    Current Hematologic Malignancy Reports, 2012, 7 : 235 - 240
  • [23] Increased CCR4 expression in cutaneous T cell lymphoma
    Ferenczi, K
    Fuhlbrigge, RC
    Pinkus, JL
    Pinkus, GS
    Kupper, TS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (06) : 1405 - 1410
  • [24] CCR4 and CCR5 expression in a case of subcutaneous panniculitis-like T-cell lymphoma
    Naomi Kitayama
    Atsushi Otsuka
    Yuki Honda
    Yumi Matsumura
    Tetsuya Honda
    Kenji Kabashima
    European Journal of Dermatology, 2017, 27 : 414 - 415
  • [25] CCR4 and CCR5 expression in a case of subcutaneous panniculitis-like T-cell lymphoma
    Kitayama, Naomi
    Otsuka, Atsushi
    Honda, Yuki
    Matsumura, Yumi
    Honda, Tetsuya
    Kabashima, Kenji
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (04) : 414 - 415
  • [26] Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas
    Remer, Marcus
    Al-Shamkhani, Aymen
    Glennie, Martin
    Johnson, Peter
    IMMUNOTHERAPY, 2014, 6 (11) : 1187 - 1206
  • [27] Mogamulizumab for the treatment of T-cell lymphoma
    Makita, Shinichi
    Tobinai, Kensei
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (09) : 1145 - 1153
  • [28] North American Adult T-Cell Leukemia/Lymphoma Has Frequent Mutations in CCR4 and Responds in Vitro to a Small Molecule CCR4 Antagonist, CCR4-351
    Ye, B. Hilda
    Liu, Eric
    Pradhan, Kith
    Guillen, Erik
    Shah, Urvi A.
    Shastri, Aditi
    Lauvau, Gregoire
    Janakiram, Murali
    Sica, Alejandro
    Kassner, Paul D.
    Verma, Amit
    BLOOD, 2023, 142
  • [29] CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma
    Yuma Sakamoto
    Keiichiro Fujii
    Shunji Murase
    Satsuki Nakano
    Ayako Masaki
    Takayuki Murase
    Shigeru Kusumoto
    Shinsuke Iida
    Atae Utsunomiya
    Ryuzo Ueda
    Takashi Ishida
    Hiroshi Inagaki
    International Journal of Hematology, 2019, 110 : 389 - 392
  • [30] CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma
    Sakamoto, Yuma
    Fujii, Keiichiro
    Murase, Shunji
    Nakano, Satsuki
    Masaki, Ayako
    Murase, Takayuki
    Kusumoto, Shigeru
    Iida, Shinsuke
    Utsunomiya, Atae
    Ueda, Ryuzo
    Ishida, Takashi
    Inagaki, Hiroshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (04) : 389 - 392
12345